cytosine has been researched along with Lymphoma, B-Cell in 12 studies
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Epigenetic diversity is linked to unfavorable clinical outcomes, clonal selection at relapse, and is driven at least in part because of the actions of activation-induced cytosine deaminase, which is a unique feature of B-cell lymphomas." | 4.93 | The many layers of epigenetic dysfunction in B-cell lymphomas. ( Dominguez, PM; Jiang, Y; Melnick, AM, 2016) |
| "The 5'-end of the P1 promoter of the B-cell lymphoma-2 (bcl-2) gene contains a highly guaninecytosine-rich region, which has a role in the regulation of bcl-2 transcription." | 3.74 | Solution equilibria of the i-motif-forming region upstream of the B-cell lymphoma-2 P1 promoter. ( Aviñó, A; Eritja, R; Gargallo, R; González, C; Khan, N; Tauler, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coen, N | 1 |
| Duraffour, S | 1 |
| Naesens, L | 1 |
| Krecmerová, M | 1 |
| Van den Oord, J | 1 |
| Snoeck, R | 1 |
| Andrei, G | 1 |
| Krokan, HE | 2 |
| Sætrom, P | 2 |
| Aas, PA | 2 |
| Pettersen, HS | 2 |
| Kavli, B | 2 |
| Slupphaug, G | 2 |
| Matsuda, I | 1 |
| Imai, Y | 1 |
| Hirota, S | 1 |
| Galashevskaya, A | 1 |
| Doseth, B | 1 |
| Sousa, MM | 1 |
| Sarno, A | 1 |
| Visnes, T | 1 |
| Liabakk, NB | 1 |
| Cimmino, L | 1 |
| Dawlaty, MM | 1 |
| Ndiaye-Lobry, D | 1 |
| Yap, YS | 1 |
| Bakogianni, S | 1 |
| Yu, Y | 1 |
| Bhattacharyya, S | 1 |
| Shaknovich, R | 1 |
| Geng, H | 1 |
| Lobry, C | 1 |
| Mullenders, J | 1 |
| King, B | 1 |
| Trimarchi, T | 1 |
| Aranda-Orgilles, B | 1 |
| Liu, C | 1 |
| Shen, S | 1 |
| Verma, AK | 1 |
| Jaenisch, R | 1 |
| Aifantis, I | 1 |
| Rasmussen, KD | 1 |
| Helin, K | 1 |
| Jiang, Y | 1 |
| Dominguez, PM | 1 |
| Melnick, AM | 1 |
| Luppi, M | 1 |
| Trovato, R | 1 |
| Barozzi, P | 1 |
| Vallisa, D | 1 |
| Rossi, G | 1 |
| Re, A | 1 |
| Ravazzini, L | 1 |
| Potenza, L | 1 |
| Riva, G | 1 |
| Morselli, M | 1 |
| Longo, G | 1 |
| Cavanna, L | 1 |
| Roncaglia, R | 1 |
| Torelli, G | 1 |
| Khan, N | 1 |
| Aviñó, A | 1 |
| Tauler, R | 1 |
| González, C | 1 |
| Eritja, R | 1 |
| Gargallo, R | 1 |
| Robertson, KD | 1 |
| Manns, A | 1 |
| Swinnen, LJ | 1 |
| Zong, JC | 1 |
| Gulley, ML | 1 |
| Ambinder, RF | 1 |
| Hocqueloux, L | 1 |
| Agbalika, F | 2 |
| Oksenhendler, E | 2 |
| Molina, JM | 2 |
| Boulanger, E | 1 |
| Maarek, O | 1 |
| Daniel, MT | 1 |
| Grollet, L | 1 |
| Sigaux, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Epigenetics, Vitamin C, and Abnormal Hematopoiesis - Role of Vitamin C in Epigenetic Regulation in Hematopoiesis Sub-Study on CCUS, Low-Risk MDS, and CMML-0/1[NCT03682029] | 109 participants (Actual) | Interventional | 2017-11-21 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for cytosine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
Topics: Adaptive Immunity; Animals; APOBEC-1 Deaminase; Cytidine Deaminase; Cytosine; DNA Glycosylases; DNA | 2014 |
The many layers of epigenetic dysfunction in B-cell lymphomas.
Topics: Cell Transformation, Neoplastic; Chromatin; Clonal Evolution; Cytosine; Dioxygenases; DNA Methylatio | 2016 |
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; | 2001 |
9 other studies available for cytosine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cells, Cultured; Cidofovir; Cyclic AMP; Cyt | 2013 |
Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Epigenesis, | 2014 |
AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Topics: Base Pair Mismatch; Cell Line, Tumor; Cytidine Deaminase; Cytosine; Deamination; DNA Repair; DNA, Ne | 2015 |
TET1 is a tumor suppressor of hematopoietic malignancy.
Topics: 5-Methylcytosine; Animals; B-Lymphocytes; Cell Differentiation; Cell Lineage; Chromosomal Instabilit | 2015 |
TET1: an epigenetic guardian of lymphomagenesis.
Topics: Animals; B-Lymphocytes; Cytosine; DNA-Binding Proteins; Embryonic Stem Cells; Humans; Lymphoma, B-Ce | 2015 |
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2005 |
Solution equilibria of the i-motif-forming region upstream of the B-cell lymphoma-2 P1 promoter.
Topics: Amino Acid Motifs; Base Sequence; Circular Dichroism; Cytosine; DNA; Humans; Hydrogen-Ion Concentrat | 2007 |
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Topics: 5-Methylcytosine; Anemia, Aplastic; Burkitt Lymphoma; CpG Islands; Cytosine; DNA (Cytosine-5-)-Methy | 1996 |
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Age | 2001 |